Boundless Bio is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors.
Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026 Company to disclose clinical safety and ...
Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results